Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial

[1]  S. Yusuf,et al.  Rationale and design of the steroids in cardiac surgery trial. , 2014, American heart journal.

[2]  J. Tijssen,et al.  Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. , 2012, JAMA.

[3]  G. Hillis,et al.  Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery , 2012 .

[4]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[5]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[6]  S. Chauhan,et al.  Is EuroSCORE applicable to Indian patients undergoing cardiac surgery? , 2010, Annals of cardiac anaesthesia.

[7]  Lin Han,et al.  Validation of the European system for cardiac operative risk evaluation (EuroSCORE) in Chinese heart valve surgery patients. , 2010, The Journal of heart valve disease.

[8]  K. Ho,et al.  Benefits and Risks of Corticosteroid Prophylaxis in Adult Cardiac Surgery: A Dose-Response Meta-Analysis , 2009, Circulation.

[9]  K. Thorlund,et al.  Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. , 2008, European heart journal.

[10]  J. Alpert,et al.  Universal definition of myocardial infarction. , 2007, European heart journal.

[11]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[12]  F. Farrokhyar,et al.  Pulse low dose steroids attenuate post-cardiopulmonary bypass SIRS; SIRS I. , 2006, The Journal of surgical research.

[13]  R. Whitlock,et al.  Pro: Steroids should be used for cardiopulmonary bypass. , 2005, Journal of cardiothoracic and vascular anesthesia.

[14]  Xiang Xiaoyong,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment , 2005 .

[15]  F. Van de Werf,et al.  Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. , 2004, JAMA.

[16]  T. Mesana,et al.  The inflammatory response to cardiopulmonary bypass: a therapeutic overview , 2004, Perfusion.

[17]  Madhu Mazumdar,et al.  Methods for categorizing a prognostic variable in a multivariable setting , 2003, Statistics in medicine.

[18]  M. Chaney.  Corticosteroids and cardiopulmonary bypass : a review of clinical investigations. , 2002, Chest.

[19]  T. Yau,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  M. Entman,et al.  The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.

[21]  J. Levy,et al.  Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. , 2001, The Annals of thoracic surgery.

[22]  M Mazumdar,et al.  Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. , 2000, Statistics in medicine.

[23]  J. Vincent,et al.  Steroids in cardiopulmonary bypass. , 2000, Critical care medicine.

[24]  M. Goldman.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints , 2000 .

[25]  K. Taylor,et al.  Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. , 1999, The Annals of thoracic surgery.

[26]  S. Lemeshow,et al.  European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[27]  S. Nashef,et al.  Eurp-pean system for cardiac operative risk evaluation (Euro SCORE) , 1999 .

[28]  J. Devière,et al.  Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. , 1997, American heart journal.

[29]  E. Verrier,et al.  Endothelial cell injury in cardiovascular surgery. , 1996, The Annals of thoracic surgery.

[30]  D. Royston,et al.  Preventing the inflammatory response to open-heart surgery: the role of aprotinin and other protease inhibitors. , 1996, International journal of cardiology.

[31]  J. Gauldie,et al.  Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. , 1995, Circulation.

[32]  Kirklin Jk,et al.  Early complications following cardiac surgery. , 1987 .

[33]  S Westaby,et al.  Complement and the damaging effects of cardiopulmonary bypass. , 1983, The Journal of thoracic and cardiovascular surgery.

[34]  E. Braunwald,et al.  Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. , 1983, Circulation.

[35]  R Roberts,et al.  Deleterious effects of methylprednisolone in patients with myocardial infarction. , 1976, Circulation.

[36]  W. Roberts,et al.  Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm. , 1974, The American journal of medicine.